Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 42

Trial Status

Completed4
Recruiting1
Terminated1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT03848481Phase 2Terminated
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
Prader-Willi Syndrome
PrincipalinvestigatorStart date: 2020-11-23
NCT03202303Phase 2Recruiting
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder
PrincipalinvestigatorStart date: 2019-04-12
NCT00245635Phase 4Completed
Fluoxetine in Pediatric Body Dysmorphic Disorder
Body Dysmorphic Disorder
Principalinvestigator
NCT01040221Phase 1Completed
Trichuris Suis Ova in Autism Spectrum Disorders
Autism
Principalinvestigator
NCT01337687Not ApplicableCompleted
Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders
Autism Spectrum Disorders
Principalinvestigator
NCT01337700Phase 4Completed
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Asperger SyndromeAspergers SyndromeAutism Spectrum Disorder
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Montefiore Medical Center/Albert Einstein College of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Forbes D Porter, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
15 trials

Shared therapeutic areas:

Asperger SyndromeAutistic DisorderAutism Spectrum Disorder
Similarity Score18%

Barbara B Biesecker

National Human Genome Research Institute (NHGRI)

Related
23 trials

Shared therapeutic areas:

Asperger SyndromeAutistic DisorderAutism Spectrum Disorder
Similarity Score18%

Antonio Hardan, MD

Stanford University

Related
12 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score12%

Janet Wozniak, MD

Massachusetts General Hospital

Related
11 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score12%

Flavia Marino

Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Related
12 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score12%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score12%

James McCracken, MD

University of California, Los Angeles

Related
8 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder
Similarity Score12%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score12%

Susan Shur-Fen Gau, MD, PhD

National Taiwan University Hospital & College of Medicine

Related
23 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder
Similarity Score12%

Gagan Joshi, MD

Massachusetts General Hospital

Related
12 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT03848481Phase 2PrincipalInvestigator

CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)

Prader-Willi Syndrome
Terminated
NCT03202303Phase 2PrincipalInvestigator

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder
Recruiting
NCT00245635Phase 4PrincipalInvestigator

Fluoxetine in Pediatric Body Dysmorphic Disorder

Body Dysmorphic Disorder
Completed
NCT01040221Phase 1PrincipalInvestigator

Trichuris Suis Ova in Autism Spectrum Disorders

Autism
Completed
NCT01337687Not ApplicablePrincipalInvestigator

Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

Autism Spectrum Disorders
Completed
NCT01337700Phase 4PrincipalInvestigator

Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism

Asperger SyndromeAspergers SyndromeAutism Spectrum Disorder
Completed

All 6 trials loaded